DUPHASTON Israel - English - Ministry of Health

duphaston

abbott medical laboratories ltd, israel - dydrogesterone - film coated tablets - dydrogesterone 10 mg - dydrogesterone - dydrogesterone - cases where progesterone supplement is needed.

FEMOSTON 1/10 estradiol 1mg and estradiol 1mg   with dydrogesterone 10mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

femoston 1/10 estradiol 1mg and estradiol 1mg with dydrogesterone 10mg tablet blister pack

viatris pty ltd - estradiol, quantity: 1 mg (equivalent: estradiol hemihydrate, qty 1.03 mg); dydrogesterone, quantity: 10 mg - tablet, film coated - excipient ingredients: lactose monohydrate; colloidal anhydrous silica; hypromellose; maize starch; magnesium stearate; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350; ferrosoferric oxide - hormone replacement therapy (hrt) in oestrogen deficiency associated with natural or artificial menopause in women with an intact uteri. prevention of postmenopausal bone mineral density loss in women. for initiation and continuation of treatment of postmenopausal symptoms, the lowest possible effective dose for the shortest duration should be used with the goal being short term use.,hormone replacement therapy (hrt) in oestrogen deficiency associated with natural or artificial menopause in women with an intact uterus. prevention of postmenopausal bone mineral density loss in women. for initiation and continuation of treatment of postmenopausal symptoms, the lowest effective dose for the shortest duration should be used with the goal being short term use (see dosage and administration and clinical trials). when prescribed solely for the prevention of postmenopausal bone mineral density loss in women, therapy should only be prescribed for women who are at high risk of future fracture and who are intolerant of, or contraindicated for non-oestrogen products approved for prevention of osteoporosis. life style modifications and the risk benefit profile of femoston should be taken into careful consideration and discussed with the patient, to allow the patient to make an informed decision prior to prescribing( see precautions and dosage and administration).

Femoston 1/10 film-coated Tablets Malta - English - Medicines Authority

femoston 1/10 film-coated tablets

mylan products limited - dydrogesterone; estradiol - film-coated tablet - dydrogesterone 10 mg; estradiol 1 mg - sex hormones and modulators of the genital system

Femoston 2/10mg film-coated Tablets Malta - English - Medicines Authority

femoston 2/10mg film-coated tablets

mylan products limited - dydrogesterone; estradiol - film-coated tablet - dydrogesterone 10 mg; estradiol 2 mg - sex hormones and modulators of the genital system

FEMOSTON 110 MG Israel - English - Ministry of Health

femoston 110 mg

abbott medical laboratories ltd, israel - dydrogesterone; estradiol; estradiol - film coated tablets - dydrogesterone 10 mg; estradiol 1 mg; estradiol 1 mg - dydrogesterone and estrogen - hormone replacement therapy (hrt) for estrogen deficiency symptoms in menopausal women at least 6 months since last menses.prevention of osteoporosis in postmenopausal women at high risk of future fractures. femoston 1/10 should only be used in patients who are intolerant of other products, approved for the prevention of osteoporosis or for whom these products are contra-indicated.femoston is indicated for women with an intact uterusexperience with treatment of women older than 65 years is limited.

Femoston conti Tablet, film coated 1mg/5mg Malta - English - Medicines Authority

femoston conti tablet, film coated 1mg/5mg

mylan products limited - dydrogesterone; estradiol - film-coated tablet - dydrogesterone 5 mg; estradiol 1 mg - sex hormones and modulators of the genital system

Femoston-Conti 0.5mg/2.5mg, film-coated Tablets Malta - English - Medicines Authority

femoston-conti 0.5mg/2.5mg, film-coated tablets

mylan products limited - dydrogesterone; estradiol - film-coated tablet - dydrogesterone 2.5 mg; estradiol 0.5 mg - sex hormones and modulators of the genital system

Femoston-conti 1mg/5mg film-coated Tablets Malta - English - Medicines Authority

femoston-conti 1mg/5mg film-coated tablets

mylan ire healthcare limited unit 35/36, grange parade, baldoyle industrial estate, dublin 13, ireland - dydrogesterone, estradiol - film-coated tablet - dydrogesterone 5 mg estradiol 1 mg - sex hormones and modulators of the genital system

FEMOSTON 2/10 estradiol 2mg and estradiol 2mg   with Dydrogesterone 10mg tablet blister pack (CP) Australia - English - Department of Health (Therapeutic Goods Administration)

femoston 2/10 estradiol 2mg and estradiol 2mg with dydrogesterone 10mg tablet blister pack (cp)

viatris pty ltd - dydrogesterone, quantity: 10 mg; estradiol, quantity: 2 mg - tablet, film coated - excipient ingredients: magnesium stearate; hypromellose; colloidal anhydrous silica; lactose monohydrate; maize starch; titanium dioxide; iron oxide yellow; purified talc; macrogol 400 - hormone replacement therapy (hrt) in oestrogen deficiency associated with natural or artificial menopause in women with an intact uterus. prevention of postmenopausal bone mineral density loss in women. for initiation and continuation of treatment of postmenopausal symptoms, the lowest effective dose for the shortest duration should be used with the goal being short term use (see dosage and administration and clinical trials). when prescribed solely for the prevention of postmenopausal bone mineral density loss in women, therapy should only be prescribed for women who are at high risk of future fracture and who are intolerant of, or contraindicated for non-oestrogen products approved for prevention of osteoporosis. life style modifications and the risk benefit profile of femoston should be taken into careful consideration and discussed with the patient, to allow the patient to make an informed decision prior to prescribing( see precautions and dosage and administration).